Noticias de PPCB_US

Noticias del mercado

Últimas noticias sobre PPCB_US — 31 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PPCB_US ✕ 31 resultados
28/03/2026 PPCB_US — Xã Châu Thành
What should investors watch in Propanc Biopharma (PPCB) Stock | Price at $0.10, Down 3.30% - Risk Reward Ratio
28/03/2026 PPCB_US — newser.com
What should investors watch in Propanc Biopharma (PPCB) Stock | Price at $0.10, Down 3.30% - Community Momentum Stocks
28/03/2026 PPCB_US — Xã Thanh Hà
What should investors watch in Propanc Biopharma (PPCB) Stock | Price at $0.10, Down 3.30% - Risk Reward Ratio
24/03/2026 PPCB_US — Stock Titan
Propanc extends 17-year Spain research tie to study aging and cancer
24/03/2026 PPCB_US — Yahoo Finance
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
24/03/2026 PPCB_US — BioSpace
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
19/03/2026 PPCB_US — Stock Titan
Propanc Biopharma (PPCB) approves 33M shares and 1:10–1:30 reverse split
12/03/2026 PPCB_US — Stock Titan ES ← EN
13% de supervivencia en cáncer de páncreas; La terapia con propanc alcanza >85% de inhibición tumoral
10/03/2026 PPCB_US — Stock Titan
New cancer trial prep: Propanc and FyoniBio build PRP blood test
10/03/2026 PPCB_US — Investing.com
Propanc Biopharma signs contract for Phase 1b cancer trial assay
10/03/2026 PPCB_US — The Manila Times ES ← EN
Propanc Biopharma ejecuta un acuerdo de servicio con FyoniBio para establecer y validar un ensayo farmacocinético para el primer estudio de fase 1b en humanos

Página 2 de 2

keyboard_arrow_up